Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical validation and applicability of different tipranavir/ritonavir genotypic scores in HIV-1 protease inhibitor-experienced patients.

Current HIV research - 1 Jul 2009

Saracino Annalisa, Monno Laura, Tartaglia Alessandra, Tinelli Carmine, Seminari Elena, Maggiolo Franco, Bonora Stefano, Rusconi Stefano, Micheli Valeria, Lo Caputo Sergio, Lazzaroni Laura, Ferrara Sergio, Ladisa Nicoletta, Nasta Paola, Parruti Giustino, Bellagamba Rita, Forbici Federica, Angarano Gioacchino

Abstract excerpt

Tipranavir, a non-peptidic protease inhibitor which shows in vitro efficacy against some HIV-1-resistant strains, can be used in salvage therapies for multi-experienced HIV patients due to its peculiar resistance profile including 21 mutations at 16 protease positions according to International A...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Antiretroviral Therapy, Highly Active

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Protease

Share to Pyridines

Share to Pyrones

Share to Research Design

Share to Ritonavir

Share to Sulfonamides

Source

Identifiers

PMID: 19601778
DOI: 10.2174/157016209788680525

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19601778-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical validation and applicability of different tipranavir/ritonavir genotypic scores in HIV-1 protease inhibitor-experienced patients.PMID 19601778Read ↗

Do we need genotypic weighted resistance scores for antiretrovirals? The curious case of tipranavir.Semantic proximity Read ↗

Successful virological outcome in an HIV-infected individual with a three-class resistant variant and an insertion in the protease genome with a Tipranavir based regimen.Semantic proximity Read ↗

Comparison of drug resistance scores for tipranavir in protease inhibitor-naive patients infected with HIV-1 B and non-B subtypes.Semantic proximity Read ↗

Prediction of the virological response to etravirine in clinical practice: Comparison of three genotype algorithms.Semantic proximity Read ↗

Genotypic changes in human immunodeficiency virus type 1 protease associated with reduced susceptibility and virologic response to the protease inhibitor tipranavir.Semantic proximity Read ↗

Improving the prediction of virological response to tipranavir: the development and validation of a tipranavir-weighted mutation score.Semantic proximity Read ↗

Comparison of HIV type 1 protease inhibitor susceptibility results in viral samples analyzed by phenotypic drug resistance assays and by six resistance algorithms: an analysis of a subpopulation of the CHORUS cohort.Semantic proximity Read ↗

Changes in darunavir/r resistance score after previous failure to tipranavir/r in HIV-1-infected multidrug-resistant patients.Semantic proximity Read ↗

Tipranavir: a new protease inhibitor for the treatment of antiretroviral-experienced HIV-infected patients.Semantic proximity Read ↗

Interpretation of genotypic HIV-1 resistance to darunavir and virological response: validation of available systems and of a new score.Semantic proximity Read ↗

Tipranavir/T20-based salvage regimens highly effective and durable against HIV-1 with evidence for genotypic predictability of response in clinical practice.Semantic proximity Read ↗

Predictive genotypic algorithm for virologic response to lopinavir-ritonavir in protease inhibitor-experienced patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.